SciELO - Scientific Electronic Library Online

vol.63 issue6Seroprevalence of SARS-CoV-2 in adults and older adults in Mexico and its association with chronic diseases. Ensanut 2020 Covid-19Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020 author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • Have no similar articlesSimilars in SciELO


Salud Pública de México

Print version ISSN 0036-3634


ROJAS-MARTINEZ, Rosalba et al. Trends in the prevalence of metabolic syndrome and its components in Mexican adults, 2006-2018. Salud pública Méx [online]. 2021, vol.63, n.6, pp.713-724.  Epub Feb 27, 2023. ISSN 0036-3634.


To examine trends in the prevalence of metabolic syndrome (MS) and its components.

Materials and methods:

Data from 27 800 Mexican adults who participated in Ensanut 2006, 2012, 2016 and 2018 were analyzed. Linear regression was used across each Ensanut period to assess temporal linear trends in the prevalence of MS. Logistic regression models were obtained to calculate the percentage change, p-value for the trend and the association between the presence of MS and the risk of developing type 2 diabetes mellitus (T2DM) over 10 years using the Finnish Diabetes Risk Score (FINDRISC) and cardiovascular disease (CVD) using Globorisk.


The prevalence of MS in Mexican adults according to the harmonized definition was: 40.2, 57.3, 59.99 and 56.31%, in 2006, 2012, 2016 and 2018 respectively (p for trend <0.0001). In 2018, 7.62% of metabolic syndrome cases had a significant risk for incident DM2 and 11.6% for CVD.


It is estimated that there are 36.5 million Mexican adults living with metabolic syndrome, of which 2 million and 2.5 million have a high risk of developing T2DM or cardiovascular disease respectively, over the next 10 years.

Keywords : syndrome; prevalence; trends; Ensanut.

        · abstract in Spanish     · text in English     · English ( pdf )